Swander Pace Capital has finalized its sale of over-the-counter products portfolio company Insight Pharmaceuticals. The business was sold to Prestige Brands Holdings for $750 million.
Phoenix Equity’s Nineteen Group acquires exhibitions organizer Blueprint Event Company
14 hours ago · 1 min read
Platinum Equity seals deal for Chicago propane distributor EDP
14 hours ago · 2 mins read
Industrial Growth Partners inks sale of AdvancedPCB to Amphenol
15 hours ago · 2 mins read
Avance-backed Alchemy Technology Group buys Austin cybersecurity provider Freeit Data Solutions
15 hours ago · 1 min read
A&M Capital buys majority stake in insurance investigations firm Delta Group
15 hours ago · 2 mins read
Hunter Point Capital provides preferred financing to Denver’s Bow River Capital
17 hours ago · 2 mins read
OceanSound-backed Burns Engineering buys district energy engineering firm PRVN Consultants
17 hours ago · 1 min read
